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INTRODUCTION
Acinetobacter sp. isolates are problematic pathogens in intensive-care units and other hospital units in recent years. They are the causes of health care associated pneumonia, surgical site infections, bloodstream infections, urinary tract infections (Tolbat et al., 2006). Acinetobacter sp. isolates with multi drug resistance (MDR) are markedly increasing and treatment of Acinetobacter sp. infections have been limited to few broad spectrum antibiotics, including carbapenems, amikacin, doxycycline, minocycline, and ampicillin/sulbactam (Van Looveren and Guossens, 2004). As resistance to antibiotics has emerged, the mortality rates in Acinetobacter sp. infected patients have increased. Therefore, the popularity of natural essential oils as alternative treatment has increased ( In this research, we isolated 35 clinical isolates of Acinetobacter sp. and determined the sensitivity of these isolates to different antibiotics; then we evaluate the anti Acinetobacter sp. activity of ten essential oils alone against clinical isolates of Acinetobacter sp. The combination of ten different essential oils with amikacin (AMI) was evaluated against one AMI resistant isolates by measuring the FIC and FIC indexes.
MATERIAL AND METHODS

Essential oils and their analysis
10 different essential oils including Cymbopogon olivieri, Heracleum persicum, Juniperus comminus, Azillia eryngioides, Dacus carrota, Ferula gummosa, Acorus calamus, Mentha pulegium, Achillea biebersteinii and Chaerophyllum macropodum were prepared from Barij Essence Pharmaceutical Company. The essential oils were analyzed using GC-FID and GC-MS. The GC-FID and GC-MS apparatus were conducted on an HP 6890 GC system coupled with 5973 network mass selective detectors with a capillary column of HP-5MS (30 m × 0.25 mm, film thickness 0.25 μm). The oven temperature program was initiated at 60 °C, held for 1 min, then raised up to 245 °C at a rate of 3 °C/min held for 10 min. Helium was used as the carrier gas at a flow rate 1.5 ml/min. The detector and injector temperatures were 250 and 230 °C, respectively. The compounds of the essential oil were identified by comparison of their retention indices (RI), mass spectral fragmentation with those in the stored Wiley 7n.1 mass computer library (Adams, 2001).
Antibiotics
The antibiotic discs that were used in this study including ciprofloxacine (CIPR 5 µg), cefepime (FEP 30 µg), ceftazidime (CAZ 30 µg), levofloxacin (LEVOF 5 µg), amikacin (AMI 30 µg), amoxicillin (AMOXY 30 µg), Imipenem (IMI 10 µg), tobramycin (TOB 10 µg), cefotaxim (CTX 30 µg), norfloxacin (NOR 10 µg), ampicillin+sulbactam (SAM 20 µg (10+10)), meropenem (MRP 10 µg), gentamicin (GEN 10 µg), piperacillin+tazobactum (PI 100+ IZ 10 µg), amoxicillin+clavulonate (AMC 30 µg; (20+10)) were purchased from Rosco (Diagnostica A/S, Taastrupgaardsvej 30 DK-2630 Taastrup).
Acinetobacter isolates and antimicrobial susceptibility testing
A total of 35 clinical isolates cultured from different samples of wounds, trachea, blood, CSF, catheter and other samples of patients at hospitals from Tehran were the subject of this investigation. Antimicrobial susceptibility testing was evaluated using disc diffusion (NCCLS, 2012) and micro broth (CLSI, 2009) dilution assays. This inoculate of microorganism was adjusted to 0.5 McFarland (1×10 7 -1×10 8 CFU/ml) and using a sterile cotton swab, the microbial suspensions were cultured on appropriate media. Subsequently, sterile blank discs (6 mm in diameter) were saturated with 0.5, 1 and 2 µl of essential oil and were put on the cultured media. The plates were incubated at 37 °C for 24 h. The inhibition zones (IZ) diameters were measured in millimeters (mm) and average of IZ was recorded as means ± SD (Standard Deviation). The minimal inhibitory concentration (MIC) and minimal Bactericidal Concentration (MBC) values of essential oils were determined by micro broth dilution assay. The essential oil was twofold serially diluted (8 -0.0125 µl/ml of essential oil). Cation adjusted Muller Hinton broth was used as broth media. After shaking, 100 µl of essential oil was added to each well. The above microbial suspensions were diluted to 1×10 6 and then 100 µl were added to each well and incubated at 35±2 °C. MIC was defined as the lowest concentration of essential oil that inhibits bacteria after 24 h. MBC value was the first well that Acinetobacter sp. as gram negative bacilli is one of the most problematic bacteria in hospital environments. The emergence of multidrug resistant isolates of Acinetobacter sp. encourages the scientists to find the new antimicrobial agent with less side effects. The aim of this study was to evaluate the antibacterial activity of Cymbopogon olivieri, Heracleum persicum, Juniperus comminus, Azillia eryngioides, Dacus carrota, Ferula gummosa, Acorus calamus, Mentha pulegium, Achillea biebersteinii, and Chaerophyllum macropodum essential oils against clinical trials of Acinetobacter sp. by disc diffusion and micro broth dilution assays. The synergistic effect of these essential oils and amikacin (AMI) were determined. The higher inhibition zone diameters were for 2 µl of C. macropodum (15.3±0.48 mm). The lower MIC and MBC values were for C. olivieri (1.4 and 1.9 µl/ml) and J. comminus (1.9 and 2.6 µl/ml), followed by C. macropodum (2.01 and 3.2 µl/ml), D. carrota (2.1 and 3.8 µl/ml), A. eryngioides (2.3 and 3.1 µl/ml) essential oils and F. gummosa (2.4 and 4 µl/ml). AMI showed synergistic effect with all of the essential oils. D. carrota and A. eryngioides showed the best synergistic effect with AMI, followed by C. macropodum, A. biebersteinii, J. comminus and F. gummosa essential oils.
showed no growth on suitable media. All experiments were done in triplicates.Statistical data analysis was performed by SPSS software (version 17, Chicago, Illinois, USA). Statistical analysis (ANOVA) was applied to determine the differences (P<0.05). Significant differences between the essential oils and microorganisms were determined by Tukey test.
Checkerboard titer test
AMI were purchased from Sigma-Aldrich Co. LLC. and dissolved in water. The dilutions were prepared in water in concentration 64-0.0125 µg/ml and the antimicrobial susceptibility testing was performed as CLSI procedure (CLSI, 2009) . Eight serial twofold dilutions of essential oils and AMI were used. Fifty µl of each dilution of essential oil was added to the wells of 96-well plates in vertical orientation and 10 µl of AMI dilution was added in horizontal orientation. 50 µl of AMI resistant Acinetobacter sp (10 6 CFU/ well) was added to each well and incubated for 24 h. Fractional inhibitory concentrations (FICs) were calculated as the MIC of the combination of essential oil and AMI divided by the MIC of essential oil or AMI alone. The FIC index (FICI) was interpreted as a synergistic effect when it was ≤0.5, as additive or indifferent when it was >0.5-2 and as antagonistic when it was>2.0 (Rosato et al., 2007). 
RESULTS AND DISCUSSION
Resistance of Acinetobacter sp to antibiotics
As the tab 1 is shown, the resistant profile of 35 clinical isolates were included: CIPR (65.7%), CTX (60%), CAZ (74.2%), LEVOF (48.6%), AMI (42.9%), AMOXY (97.1%), IMI (65.7%), TOB (25.7%), CTX (91.4%), NORFX (74.3%), SAM (60%), MRP (74.3%), GEN (71.4%), PI+IZ (62.8%), AMC (74.2%). The higher sensitivity was for TOB and AMI (tab 1).
Chemical composition and antibacterial screening
The antibacterial evaluation of essential oils against clinical isolates of Acinetobacter sp. by disc diffusion method showed that the activity was increased dose dependently. Increasing in the amount of essential oils increased the inhibition zone diameter of essential oils (tab 3). The higher inhibition zone diameters were for 2 µl of C. macropodum (15.3±0.48 mm), and H. persicum (13.3±0.48 mm). The main components of H. persicum was n-octyl acetate (72.3%), 2-methyloctyl ester butanoic acid (5.5%), 1-octanol (4.2%) while the chemical composition of C. macropodum showed the presence of trans-ocimene (49.2%), cis-ocimene (23.6%), γ-terpinene (7.7%), β-myrcene (4.4%), p-cymene (5.5%), and fenchyl acetate (2.7%) as the main components (tab 2). 
Dacus carrota
Carotol (46.1%), 3-octen-5-yne,2,7-dimethyl-(z) (15.7%), α-pinene (10.7%), trans caryophyllene (4.6%), trans-β-farnesene (4.5%), α-bergamotene (2.53%)
Ferula gummosa β-pinene (62.7%), α-pinene (9.5%), δ-carene (7.5%)
Acorus calamus
Cis-asarone (27.5%), acorenone (17.4%), elemene (8.9%), α-salinene (7.2%), camphor (3.1%), camphene (2.6%)
Mentha pulegium
Piperitone (38.1%), piperitenone (33.1%), α-terpineol (4.8%), 1,8-cineole (4.1%), piperitenone oxide (3.4%), menthone (3.0%)
Achillea biebersteinii
Germacrene-D (46.6%), camphor (6.2%), 1,8-cineole (5.2%), bicyclogemacrene (4.8%), spathulenol (3.8%)
Chaerophyllum macropodum
trans-ocimene (49.2%), cis-ocimene (23.6 %), γ-terpinene (7.7 %), β-myrcene (4.4 %), p-cymene (5.8 %), and fenchyl acetate (2.7 %)
As we mentioned before, the higher sensitivity of antibiotics against clinical isolates of Acinetobacter sp. was for tobramycin, AMI and levofloxacin. The inhibition zone diameter of these antibiotics was 14.1, 10.5 and 12.5 mm respectively and was lower than C. macropodum essential oil. The MIC and MBC evaluation of these essential oils showed the different results with disc diffusion method. The lower MIC and MBC values were for C. olivieri essential oil (1.4 and 1.9 µl/ml) and J. comminus (1.9 and 2.6 µl/ml) followed by C. macropodum (2.01 and 3.2 µl/ml), D. carrota (2.1 and 3.8 µl/ml), A. eryngioides (2.3 and 3.1 µl/ml) and F. gummosa (2.4 and 4 µl/ml) essential oils. Piperitone (72.8%), 4-carene (11.8%), β-himachalene (7.6%) were found in C. olivieri essential oil. Camphene (37.7%), β-pinene (15.7%), γ-terpinene (12%), murola-4(14), 5-diene (trans) (11.8%), α-terpinene (1.89%) were the main components of J. comminus essential oil. The MIC values for H. persicum (3.5 µl/ml), A. biebersteinii (3.6 µl/ml), A. calamus (3.9 µl/ml) essential oils were almost the same but the MBC values were 4.8, 5.7 and 6.5 µl/ml, respectively. Therefore, there is no correlation between the inhibition zone diameter and MIC values (P>0.05).
The inhibition zone diameters of these antibiotics were 14.1, 10.5 and 12.5 mm, respectively and was lower than C. macropodum essential oil. The MIC and MBC evaluation of these essential oils showed the different results with disc diffusion method. The lower MIC and MBC values were for C. olivieri essential oil (1.4 and 1.9 µl/ml) and J. comminus (1.9 and 2.6 µl/ml) followed by C. macropodum (2.01 and 3.2 µl/ml), D. carrota (2.1 and 3.8 µl/ml), A. eryngioides (2.3 and 3.1 µl/ml) and F. gummosa (2.4 and 4 µl/ml) essential oils. Piperitone (72.8%), 4-carene (11.8%), β-himachalene (7.6%) were found in C. olivieri essential oil. Camphene (37.7%), β-pinene (15.7%), γ-terpinene (12%), murola-4(14),5-diene (trans) (11.8%), α-terpinene (1.89%) were the main components of J. comminus essential oil. The MIC values for H. persicum (3.5 µl/ml), A. biebersteinii (3.6 µl/ml), A. calamus (3.9 µl/ml) essential oils were almost the same but the MBC values were 4.8, 5.7 and 6.5 µl/ml, respectively. Therefore, there is no correlation between the inhibition zone diameter and MIC values (P>0.05). 
Synergistic evaluation
The synergistic evaluation of essential oils and AMI showed synergistic effect (the FICI was lower than 0.5). 
CONCLUSION
This study evaluate the antibacterial activity of ten essential oils against clinical isolates of Acinetobacter sp. The results of antibacterial screening showed different essential oils with different chemical composition has different antibacterial activity. Among ten essential oils,C. macropodum, C. olivieri and J. comminus (1.9 and 2.6 µl/ml) has the higher antibacterial activity against Acinetobacter sp. AMI showed synergistic effect with all of the essential oils. D. carrota and A. eryngioides showed the best synergistic effect with AMI, followed by C. macropodum, A. biebersteinii,J. comminus and F. gummosa essential oils.Therefore, these essential oils can be as alternative treatment for lowering dose of AMI. More clinical studies are required to providing these essential oils in clinical.
